Specifications
Properties
Additional Info
Background
Specifications
| SPECIES REACTIVITY: | Human |
|---|---|
| HOMOLOGY: | Predicted species reactivity based on immunogen sequence: Mouse: (73%) |
| TESTED APPLICATIONS: | ELISA, IHC-P, WB |
| APPLICATIONS: | ILPIP antibody can be used for the detection of ILPIP by Western blot at 0.5 to 2 μg/mL. Aa 34 kDa band can be detected. Antibody can also be used for immunohistochemistry starting at 5 μg/mL. Antibody validated: Western Blot in human samples and Immunohistochemistry in human samples. All other applications and species not yet tested. |
| USER NOTE: | Optimal dilutions for each application to be determined by the researcher. |
| POSITIVE CONTROL: | 1) Cat. No. 1301 - Human Heart Tissue Lysate |
| 2) Cat. No. 10-501 - Human Heart Tissue Slide | |
| SPECIFICITY: | Anti-ILPIP is specific for human ILPIP only. |
| IMMUNOGEN: | ILPIP antibody was raised against a synthetic peptide corresponding to amino acids at the C-terminus of human ILPIP. The immunogen is located within the last 50 amino acids of ILPIP. |
| HOST SPECIES: | Rabbit |
Properties
| PURIFICATION: | ILPIP Antibody is affinity chromatography purified via peptide column. |
|---|---|
| PHYSICAL STATE: | Liquid |
| BUFFER: | ILPIP Antibody is supplied in PBS containing 0.02% sodium azide. |
| CONCENTRATION: | 1 mg/mL |
| STORAGE CONDITIONS: | ILPIP antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. |
| CLONALITY: | Polyclonal |
| ISOTYPE: | IgG |
| CONJUGATE: | Unconjugated |
Additional Info
| ALTERNATE NAMES: | ILPIP Antibody: PAPK, ILPIP, ILPIPA, ALS2CR2, CALS-21, PRO1038, STE20-related kinase adapter protein beta, Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein, STRAD beta |
|---|---|
| ACCESSION NO.: | NP_061041 |
| PROTEIN GI NO.: | 13027388 |
| OFFICIAL SYMBOL: | STRADB |
| GENE ID: | 55437 |
Background
| BACKGROUND: | ILPIP Antibody: ILPIP (ILP-interacting protein) has recently been shown to interact with XIAP, a member of the IAP (Inhibitor of Apoptosis) protein family. Together, these two proteins synergistically activate the TAK1/JNK1 signal transduction pathway, which acts to protect against the interleukin-1β converting enzyme of Fas-induced apotosis. This protein was independently isolated and characterized as polyploidy-associated protein kinase (PAPK), a member of the Ste20/germinal center kinase family that modulates cytoskeletal organization and cell survival, suggesting that its protective role may be a function of its kinase activity. Although two mRNA sequences have been isolated, only the shorter isoform has been observed. |
|---|---|
| REFERENCES: | 1) Sanna MG, Correia JS, Luo Y, et al. (2002) ILPIP, a novel anti-apototic protein that enhances XIAP-mediated activation of JNK and protection of apoptosis. J. Biol. Chem. 277:30454-62. | 2) Sanna MG, Duckett CS, Richter BW, et al. (1998) Selective activation of JNK1 is necessary for the anti-apototic activity of hILP. Proc. Natl. Acad. Sci USA 95:6015-20. | 3) Nishigaki K, Thompson D, Yugawa T, et al. (2003) Identification and characterization of a novel Ste20/germinal center kinase-related kinase, polyploidy-associated protein kinase. J. Biol. Chem. 278:13520-30. |
For Research Use Only
